Tag Archives: Permissible indications

TGA Advertising Portal and Complaint System now live; Industry embrace permissible indications

See: https://www.tga.gov.au/advertising-hub and: https://ajp.com.au/news/tga-explains-new-advertising-landscape/ However, there are still concerns about the transparency of the new system and my colleagues and I are holding off submitting complaints until we know: The outcome of the TGA Consultation: Complaints handling – Advertising therapeutic goods to … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment